Alto Neuroscience, Inc. (ANRO)

Alto Neuroscience Market Cap

Alto Neuroscience has a market cap or net worth of $432.83 million as of May 2, 2024.

• Market Cap: 432.83M
• Enterprise Value: 360.15M
• 1-Year Change: n/a
• Ranking: #3125
• Category: Small-Cap
• Stock Price: $16.10

Market Cap Chart

Since the IPO on February 2, 2024, Alto Neuroscience's market cap has increased from $409.04M to $432.83M, an increase of 5.82%.

Market Cap History

Date	Market Cap	% Change
Apr 30, 2024	417.00M	-0.31%
Apr 29, 2024	418.30M	9.73%
Apr 26, 2024	381.20M	0.34%
Apr 25, 2024	379.90M	-0.50%
Apr 24, 2024	381.80M	2.33%
Apr 23, 2024	373.10M	1.75%
Apr 22, 2024	366.70M	5.25%
Apr 19, 2024	348.40M	-4.00%
Apr 18, 2024	362.90M	0.14%
Apr 17, 2024	362.40M	-0.66%
Apr 16, 2024	364.80M	-4.10%
Apr 15, 2024	380.40M	-0.83%
Apr 12, 2024	383.60M	1.13%
Apr 11, 2024	379.30M	0.34%
Apr 10, 2024	378.00M	-4.55%
Apr 9, 2024	396.00M	3.66%
Apr 8, 2024	382.00M	-2.15%
Apr 5, 2024	390.40M	3.14%
Apr 4, 2024	378.50M	-0.71%
Apr 3, 2024	381.20M	0.50%
Apr 2, 2024	379.30M	-3.09%
Apr 1, 2024	391.40M	-5.16%
Mar 28, 2024	412.70M	-8.51%
Mar 27, 2024	451.10M	-6.53%
Mar 26, 2024	482.60M	7.82%

View and export this data all the way back to 2024. Sign Up Today.

Related Stocks

Company	Market Cap
Theravance Biopharma	423.85M
Aveanna Healthcare Holdings	423.23M
Pacific Biosciences of California	422.83M
Cibus	419.52M
Lexeo Therapeutics	419.09M
Voyager Therapeutics	417.57M
ZimVie	417.09M
LENZ Therapeutics	414.66M